| | Mode or medication | Weight loss produced | Duration of treatment |
| | Behaviour modification | 0.5–0.7 kg per week | — | | Cognitive-behavioral therapy | 4.5 drop in BMI | — | | Naltreoxone and buropion | 4% | — | | Phentermine and topiramate | 9% | 1 year | | Sibutramine | 10–15% | <1 year | | Orlistat | 10.2%, 8.8% | 1 year | | Orlistat | >10% | 2 years | | Orlistat | 34.6% | ? | | Amantadine | 3.5 kg | 3–6 months | | Nizatidine | Gained 3 kg less than patients who did not take Nizatidine | 16 weeks | | Naltexone | 5 kg | 8 weeks | | Topiramate augmentation | 10–15 lbs | — | | Metformin | 15/19 patients lost weight | 12 weeks |
|
|